ABRAZO WEST CAMPUS — History
CCN 030110 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$303M
Latest Revenue (FY2022)
+8.7%
Revenue CAGR (3yr)
22.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $257M | $285M | $303M | +6.4% | +8.7% |
| Operating Expenses | $215M | $235M | $236M | +0.4% | +4.7% |
| Operating Margin | 16.2% | 17.6% | 22.2% | +26.4% | +17.0% |
| Net Income | $42M | $50M | $67M | +34.4% | +27.1% |
| Licensed Beds | 191 | 197 | 207 | +5.1% | +4.1% |
| Total Patient Days | 58,734 | 61,133 | 57,256 | -6.3% | -1.3% |
| Medicare Day % | 19% | 17% | 18% | +8.7% | -2.5% |
| Medicaid Day % | 6% | 4% | 8% | +101.9% | +10.4% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +18.1% ($257M → $303M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.7%
This Hospital
+7.6%
State Avg
Latest Margin
22.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $327M | 25.2% |
| FY2024 (proj) | $350M | 28.2% |
| FY2025 (proj) | $373M | 31.2% |